The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support
Open accessAbstract
Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but large-scale, real-world data on its use are lacking. Our objective was to describe trends and variations in Impella use, clinical outcomes, and costs across US hospitals in patients undergoing percutaneous coronary intervention (PCI) treated with MCS (Impella or intra-aortic balloon pump). Methods: From the Premier Healthcare Database, we analyzed 48 306 patients undergoing PCI with MCS at 432 hospitals between January 2004 and December 2016. Association analyses were performed at 3 levels: time period, hospital, and patient. Hierarchical models with propensity adjustment were used for association analyses. We examined trends and variations in the proportion of Impella use, and associated clinical outcomes (in-hospital mortality, bleeding requiring transfusion, acute kidney injury, stroke, length of stay, and hospital costs). Results: Among patients undergoing PCI treated with MCS, 4782 (9.9%) received Impella; its use increased over time, reaching 31.9% of MCS in 2016. There was wide variation in Impella use across hospitals (>5-fold variation). Specifically, among patients receiving Impella, there was a wide variation in outcomes of bleeding (>2.5-fold variation), and death, acute kidney injury, and stroke (all ≈1.5-fold variation). Adverse outcomes and costs were higher in the Impella era (years 2008–2016) versus the pre-Impella era (years 2004–2007). Hospitals with higher Impella use had higher rates of adverse outcomes and costs. After adjustment for the propensity score, and accounting for clustering of patients by hospitals, Impella use was associated with death: odds ratio, 1.24 (95% CI, 1.13–1.36); bleeding: odds ratio, 1.10 (95% CI, 1.00–1.21); and stroke: odds ratio, 1.34 (95% CI, 1.18–1.53), although a similar, nonsignificant result was observed for acute kidney injury: odds ratio, 1.08 (95% CI, 1.00–1.17). Conclusions: Impella use is rapidly increasing among patients undergoing PCI treated with MCS, with marked variability in its use and associated outcomes. Although unmeasured confounding cannot be ruled out, when analyzed by time periods, or at the hospital level or the patient level, Impella use was associated with higher rates of adverse events and costs. More data are needed to define the appropriate role of MCS in patients undergoing PCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilevel analysis : an introduction to basic and advanced multilevel modeling
Snijders, T. A. B., & Bosker, R. (1999) · Cited by 6,832
Seyfarth, M., Sibbing, D., Bauer, I., Fröhlich, G., Bott-Flügel, L., Byrne, R., Dirschinger, J., Kastrati, A., & Schömig, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.065 · Cited by 1,090
Larsen, K. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi017 · Cited by 956
Quan, H., Li, B., Duncan Saunders, L., Parsons, G. A., Nilsson, C. I., Alibhai, A., Ghali, W. A., & for the IMECCHI Investigators (2008) · Health Services Research · doi:10.1111/j.1475-6773.2007.00822.x · Cited by 892
Ouweneel, D. M., Eriksen, E., Sjauw, K. D., van Dongen, I. M., Hirsch, A., Packer, E. J. S., Vis, M. M., Wykrzykowska, J. J., Koch, K. T., Baan, J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.022 · Cited by 890
O'Neill, W. W., Kleiman, N. S., Moses, J., Henriques, J. P. S., Dixon, S., Massaro, J., Palacios, I., Maini, B., Mulukutla, S., Džavík, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.098194 · Cited by 878
Basir, M. B., Kapur, N. K., Patel, K., Salam, M. A., Schreiber, T., Kaki, A., Hanson, I., Almany, S., Timmis, S., Dixon, S., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28307 · Cited by 448
Validity of diagnostic codes for acute stroke in administrative databases: a systematic review.
McCormick, N., Bhole, V., Lacaille, D., & Avina-Zubieta, J. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135834 · Cited by 414
Thiele, H., Jobs, A., Ouweneel, D. M., Henriques, J. P. S., Seyfarth, M., Desch, S., Eitel, I., Pöss, J., Fuernau, G., & de Waha, S. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx363 · Cited by 374
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock
Basir, M. B., Schreiber, T. L., Grines, C. L., Dixon, S. R., Moses, J. W., Maini, B. S., Khandelwal, A. K., Ohman, E. M., & O'Neill, W. W. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.037 · Cited by 361
Cited by
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Self-citationLawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
Self-citationSchrage, B., Becher, P. M., Bernhardt, A., Bezerra, H., Blankenberg, S., Brunner, S., Colson, P., Cudemus Deseda, G., Dabboura, S., Eckner, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048792 · Cited by 502
Metadata
- Authors
- Amin, A. P., Spertus, J. A., Curtis, J. P., Desai, N., Masoudi, F. A., Bach, R. G., McNeely, C., Al-Badarin, F., House, J. A., Kulkarni, H., & Rao, S. V.
- Venue
- Circulation
- Published
- 2020-01-28
- Volume
- 141
- Issue
- 4
- Pages
- 273-284
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2984895516
- Cited by
- 421
- References
- 24
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. https://app.cochat.ai/papers/10.1161/circulationaha.119.044007
- The paper
- Amin, A. P., Spertus, J. A., Curtis, J. P., Desai, N., Masoudi, F. A., Bach, R. G., McNeely, C., Al-Badarin, F., House, J. A., Kulkarni, H., & Rao, S. V. (2020). The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation. https://doi.org/10.1161/circulationaha.119.044007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.